|
Update Series (2015) Lesson 15: Where Does Shock Wave Lithotripsy Fit in 2015? Technology, Patient Selection and Techniques |
|
|
|
$0.00 |
For the most timely topics and latest surgical techniques in urology, you won’t want to miss the 2015 AUA Update Series—the AUA’s most popular self-study CME product.All new topics for 2015! |
|
Update Series (2015) Lesson 14: Cryptorchidism |
|
|
|
$0.00 |
For the most timely topics and latest surgical techniques in urology, you won’t want to miss the 2015 AUA Update Series—the AUA’s most popular self-study CME product.All new topics for 2015! |
|
Update Series (2015) Lesson 13: Principles of Immunotherapy of Genitourinary Cancer |
|
|
|
$0.00 |
For the most timely topics and latest surgical techniques in urology, you won’t want to miss the 2015 AUA Update Series—the AUA’s most popular self-study CME product.All new topics for 2015! |
|
Update Series (2015) Lesson 12: Female Urinary Incontinence: The Value and Challenges of Randomized Controlled Trials |
|
|
|
$0.00 |
For the most timely topics and latest surgical techniques in urology, you won’t want to miss the 2015 AUA Update Series—the AUA’s most popular self-study CME product.All new topics for 2015! |
|
Update Series (2015) Lesson 11: Prostatic Gizmos and Treatments for BPH: Past, Present and Future |
|
|
|
$0.00 |
For the most timely topics and latest surgical techniques in urology, you won’t want to miss the 2015 AUA Update Series—the AUA’s most popular self-study CME product.All new topics for 2015! |
|
Update Series (2015) Lesson 10: Clinical Stage I Testicular Cancer |
|
|
|
$0.00 |
For the most timely topics and latest surgical techniques in urology, you won’t want to miss the 2015 AUA Update Series—the AUA’s most popular self-study CME product.All new topics for 2015! |
|
Transmisión Web: Avances globales en cáncer de próstata: el rol de las pruebas genéticas y los inhibidores de PARP (2022) - Español |
|
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Non-Physician Participation
|
|
$0.00 |
Avances globales en cáncer de próstata: El Rol de las pruebas genéticas y los inhibidores de PARP es una nueva e interesante iniciativa global educativa que presenta una serie de cuatro cursos virtuales interactivos, basados en casos, ofrecidos en inglés, mandarín, portugués y español. En cada sesión, un moderador participará con otros dos expertos en la materia en una presentación y un debate interactivos, al estilo de una entrevista |
|
Transmisión Web: Avances globales en cáncer de próstata: Buenas prácticas en hormonoterapia para el cáncer de próstata avanzado (2022) - Español |
|
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Non-Physician Participation
|
|
$0.00 |
Avances globales en cáncer de próstata: mejores prácticas en terapia hormonal (2022) es una nueva y emocionante iniciativa educativa global en la que un moderador y otros dos expertos en la materia participarán en una presentación y debate interactivo con el estilo de una entrevista. |
|
The Journal of Urology® Volumes 209/210 Home Study Course (2023) |
|
|
|
$80.00 |
THE MOST COMPREHENSIVE AND AFFORDABLE SELF-STUDY CME PRODUCT!Make the most of your Journal of Urology® Subscription! |
|
The Journal of Urology® Volumes 207/208 Home Study Course (2022) |
|
|
|
$60.00 |
Most Comprehensive and Affordable Self-study CME Product!Make the most of your Journal of Urology® Subscription! |
|
The Journal of Urology® Volumes 205/206 Home Study Course (2021) |
|
|
|
$60.00 |
Most Comprehensive and Affordable Self-study CME Product!Make the most of your Journal of Urology® Subscription! |
|
The Journal of Urology® Volumes 203/204 Home Study Course (2020) |
|
|
|
$60.00 |
Most Comprehensive and Affordable Self-study CME Product!Make the most of your Journal of Urology® Subscription |
|
The Evolving Landscape of Advanced Prostate Cancer Treatment: A Guidelines and Case-Based Discussion Webcast (2022) |
|
- 3.25 AMA PRA Category 1 Credit™
- 3.25 Non-Physician Participation
|
|
$0.00 |
As a direct result of the significant increase in multiple FDA-approved therapeutic agents for use in patients with advanced prostate cancer, clinicians are challenged with a multitude of treatment options and potential sequencing of these agents that, consequently, make clinical decision-making more complex. This activity will build upon the updated 2020 AUA Guidelines on Metastatic Hormone Sensitive Prostate Cancer (HSPC) and Castration-Resistant Prostate Cancer (CRPC). |
|
The Evolving Landscape of Advanced Prostate Cancer Treatment: A Guidelines and Case-Based Discussion (2023) |
|
- 7.25 AMA PRA Category 1 Credit™
- 7.25 Non-Physician Participation
|
04/27/2023 |
$0.00 |
Presented by the AUA in partnership with the Society of Urologic Oncology (SUO). |
|
The Changing Face of Advanced Prostate Cancer 2022 Webcast (2022) |
|
- 2.00 AMA PRA Category 1 Credit™
- 2.00 Non-Physician Participation
|
|
$0.00 |
This is an ongoing course on advanced prostate cancer at the annual AUA since 2012 and the changes over these 10 years have been nothing less than breathtaking! In the early years, it was all about metastatic castrate resistant prostate cancer (CRPC) with multiple new therapeutic advances starting in 2010 with novel immunotherapy, AR targeted therapies and bone-targeted agents. Later, the course expanded to cover hormone sensitive (HS) advanced disease due to the new data on systemic chemotherapy and AR-directed therapy extending survival in new M1 patients. |
Facebook
Twitter
LinkedIn
Forward